Skip to main content

ADVERTISEMENT

Quiz

Test Your Knowledge
08/03/2021
The combination of first-generation EGFR-TKIs and ______ achieves a satisfactory PFS, ORR, DCR, and well-tolerated toxicity in advanced NSCLC patients with EGFR mutations.
The combination of first-generation EGFR-TKIs and ______ achieves a satisfactory PFS, ORR, DCR, and well-tolerated toxicity in advanced NSCLC patients with EGFR mutations.
The combination of...
08/03/2021
Oncology
Quiz
06/18/2021
According to study results, ___________ combination therapy displayed a hazard ratio of 0.53, the lowest hazard ratio that has been observed for survival in any phase 3 trial.
According to study results, ___________ combination therapy displayed a hazard ratio of 0.53, the lowest hazard ratio that has been observed for survival in any phase 3 trial.
According to study results,...
06/18/2021
Oncology
Quiz
08/04/2016
JCP Editors
Results of a phase III study assessing the effectiveness of biosimilar ABP 980 found that it was not inferior to which of the following drugs for the treatment of human epidermal growth factor receptor 2...
Results of a phase III study assessing the effectiveness of biosimilar ABP 980 found that it was not inferior to which of the following drugs for the treatment of human epidermal growth factor receptor 2...
...
08/04/2016
Journal of Clinical Pathways